1. Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study. (October 2022) Authors: Yu, Yongfeng; Ren, Yongxin; Fang, Jian; Cao, Lejie; Liang, Zongan; Guo, Qisen; Han, Sen; Ji, Zimei; Wang, Ye; Sun, Yulan; Chen, Yuan; Li, Xingya; Xu, Hua; Zhou, Jianying; Jiang, Liyan; Cheng, Ying; Han, Zhigang; Shi, Jianhua; Chen, Gongyan; Ma, Rui Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗